Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050141
Status:
COMPLETED
Last Update Posted:
2013-02-01
First Post:
2002-11-22
Brief Title:
Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR004030
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None